Christoffer Bruun Korfitsen, Camilla Hansen Nejstgaard, Asbjørn Hróbjartsson, Isabelle Boutron, Lisa Bero, Andreas Lundh
{"title":"同行审稿人在生物医学研究中的利益冲突:范围审查。","authors":"Christoffer Bruun Korfitsen, Camilla Hansen Nejstgaard, Asbjørn Hróbjartsson, Isabelle Boutron, Lisa Bero, Andreas Lundh","doi":"10.1136/bmjebm-2024-112967","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Peer review may improve the quality of research manuscripts and aid in editorial decisions, but reviewers can have conflicts of interest that impact on their recommendations.</p><p><strong>Objectives: </strong>The objective was to systematically map and describe the extent and nature of empirical research on peer reviewers' conflicts of interest in biomedical research.</p><p><strong>Design: </strong>Scoping review METHODS: In this scoping review, we included studies investigating peer reviewers' conflicts of interest in journal manuscripts, theses and dissertations, conference abstracts, funding applications and clinical guidelines. We searched MEDLINE, Embase, The Cochrane Methodology Register, Google Scholar (up to January 2024) and other sources. Two authors independently included studies and extracted data on key study characteristics and results, and we organised data by study domain (eg, journal manuscripts) and study aims. We included studies directly investigating peer reviewers' conflicts of interest in our primary analysis, and studies investigating other questions (eg, reasons for retraction), but reporting relevant data on peer reviewers' conflicts of interest, were solely included in a supplementary analysis.</p><p><strong>Results: </strong>After screening 44 353 references, we included 71 studies, of which 41 were included in our primary analysis. The 41 studies were published between 2005 and 2023, and 34 (83%) were journal publications. 30 (73%) studies investigated journal manuscripts, 1 (2%) conference abstracts, 4 (10%) funding applications and 6 (15%) clinical guidelines. No studies investigated theses or dissertations. 37 (90%) studies used quantitative research methods, 2 (5%) qualitative and 2 (5%) mixed methods. 21 (51%) studies investigated both financial and non-financial interests, 6 (15%) solely financial interests, 5 (12%) solely non-financial interests and 9 (22%) did not report the type of interest. We organised included studies based on study aims, with some studies having multiple aims: impact on recommendations (one study), occurrence of peer reviewers' conflicts of interest (11 studies), stakeholders' experiences (13 studies) and policy and management (22 studies). One (2%) study investigated the impact of peer reviewers' personal connections with authors on reviewers' recommendations. Nine (22%) studies estimated prevalences of conflicts of interest among peer reviewers, ranging from 3%-91%. Two (5%) studies both reported that conflicts of interest were a reason for declining to review in 1% of cases. 13 (32%) studies investigated stakeholders' experiences with peer reviewers' conflicts of interest, primarily using questionnaires of reviewers, editors and researchers. 16 (39%) studies estimated prevalences of having conflict of interest policies for peer reviewers, ranging from 5%-96%, among journals, conferences and clinical guideline organisations. Finally, six (15%) studies estimated prevalences of public availabilities of reviewers' conflicts of interest declarations, ranging from 0%-71%.</p><p><strong>Conclusions: </strong>Most studies addressed conflicts of interest in peer review of journal manuscripts, primarily through surveys of journal policies or questionnaires of researchers, editors and peer reviewers. The impact of peer reviewers' conflicts of interest on recommendations and their prevalence is still poorly understood. Our results can guide future studies and be used to align policies and management of peer reviewers' conflicts of interest.</p><p><strong>Study registration: </strong>Open Science Framework (DOI: 10.17605/OSF.IO/9QBMG).</p>","PeriodicalId":9059,"journal":{"name":"BMJ Evidence-Based Medicine","volume":" ","pages":""},"PeriodicalIF":9.0000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Peer reviewers' conflicts of interest in biomedical research: scoping review.\",\"authors\":\"Christoffer Bruun Korfitsen, Camilla Hansen Nejstgaard, Asbjørn Hróbjartsson, Isabelle Boutron, Lisa Bero, Andreas Lundh\",\"doi\":\"10.1136/bmjebm-2024-112967\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Peer review may improve the quality of research manuscripts and aid in editorial decisions, but reviewers can have conflicts of interest that impact on their recommendations.</p><p><strong>Objectives: </strong>The objective was to systematically map and describe the extent and nature of empirical research on peer reviewers' conflicts of interest in biomedical research.</p><p><strong>Design: </strong>Scoping review METHODS: In this scoping review, we included studies investigating peer reviewers' conflicts of interest in journal manuscripts, theses and dissertations, conference abstracts, funding applications and clinical guidelines. We searched MEDLINE, Embase, The Cochrane Methodology Register, Google Scholar (up to January 2024) and other sources. Two authors independently included studies and extracted data on key study characteristics and results, and we organised data by study domain (eg, journal manuscripts) and study aims. We included studies directly investigating peer reviewers' conflicts of interest in our primary analysis, and studies investigating other questions (eg, reasons for retraction), but reporting relevant data on peer reviewers' conflicts of interest, were solely included in a supplementary analysis.</p><p><strong>Results: </strong>After screening 44 353 references, we included 71 studies, of which 41 were included in our primary analysis. The 41 studies were published between 2005 and 2023, and 34 (83%) were journal publications. 30 (73%) studies investigated journal manuscripts, 1 (2%) conference abstracts, 4 (10%) funding applications and 6 (15%) clinical guidelines. No studies investigated theses or dissertations. 37 (90%) studies used quantitative research methods, 2 (5%) qualitative and 2 (5%) mixed methods. 21 (51%) studies investigated both financial and non-financial interests, 6 (15%) solely financial interests, 5 (12%) solely non-financial interests and 9 (22%) did not report the type of interest. We organised included studies based on study aims, with some studies having multiple aims: impact on recommendations (one study), occurrence of peer reviewers' conflicts of interest (11 studies), stakeholders' experiences (13 studies) and policy and management (22 studies). One (2%) study investigated the impact of peer reviewers' personal connections with authors on reviewers' recommendations. Nine (22%) studies estimated prevalences of conflicts of interest among peer reviewers, ranging from 3%-91%. Two (5%) studies both reported that conflicts of interest were a reason for declining to review in 1% of cases. 13 (32%) studies investigated stakeholders' experiences with peer reviewers' conflicts of interest, primarily using questionnaires of reviewers, editors and researchers. 16 (39%) studies estimated prevalences of having conflict of interest policies for peer reviewers, ranging from 5%-96%, among journals, conferences and clinical guideline organisations. Finally, six (15%) studies estimated prevalences of public availabilities of reviewers' conflicts of interest declarations, ranging from 0%-71%.</p><p><strong>Conclusions: </strong>Most studies addressed conflicts of interest in peer review of journal manuscripts, primarily through surveys of journal policies or questionnaires of researchers, editors and peer reviewers. The impact of peer reviewers' conflicts of interest on recommendations and their prevalence is still poorly understood. Our results can guide future studies and be used to align policies and management of peer reviewers' conflicts of interest.</p><p><strong>Study registration: </strong>Open Science Framework (DOI: 10.17605/OSF.IO/9QBMG).</p>\",\"PeriodicalId\":9059,\"journal\":{\"name\":\"BMJ Evidence-Based Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":9.0000,\"publicationDate\":\"2025-01-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ Evidence-Based Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjebm-2024-112967\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Evidence-Based Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjebm-2024-112967","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:同行评议可以提高研究稿件的质量并有助于编辑决策,但审稿人可能存在影响其推荐的利益冲突。目的:目的是系统地描绘和描述生物医学研究中同行审稿人利益冲突的实证研究的范围和性质。设计:范围审查方法:在本次范围审查中,我们纳入了调查同行审稿人在期刊手稿、论文、会议摘要、资助申请和临床指南中的利益冲突的研究。我们检索了MEDLINE, Embase, The Cochrane Methodology Register,谷歌Scholar(截止到2024年1月)和其他来源。两位作者独立纳入研究并提取关键研究特征和结果的数据,我们按研究领域(如期刊手稿)和研究目标组织数据。我们在主要分析中纳入了直接调查同行评议人利益冲突的研究,以及调查其他问题(如撤稿原因)但报告了同行评议人利益冲突相关数据的研究,这些研究仅被纳入补充分析。结果:在筛选了44353篇文献后,我们纳入了71项研究,其中41项纳入了我们的主要分析。这41项研究发表于2005年至2023年之间,其中34项(83%)发表在期刊上。30项(73%)研究调查了期刊手稿,1项(2%)研究调查了会议摘要,4项(10%)研究调查了基金申请,6项(15%)研究调查了临床指南。没有研究调查论文或学位论文。37项(90%)研究采用定量研究方法,2项(5%)采用定性研究方法,2项(5%)采用混合研究方法。21项(51%)研究同时调查了经济利益和非经济利益,6项(15%)研究仅调查了经济利益,5项(12%)研究仅调查了非经济利益,9项(22%)研究未报告利益类型。我们根据研究目标组织了纳入研究,其中一些研究有多个目标:对建议的影响(1项研究)、同行审稿人利益冲突的发生(11项研究)、利益相关者的经验(13项研究)以及政策和管理(22项研究)。一项(2%)研究调查了同行审稿人与作者的个人关系对审稿人推荐的影响。9项(22%)研究估计了同行审稿人之间利益冲突的发生率,范围在3%-91%之间。两项(5%)研究都报告说,1%的案例中,利益冲突是拒绝审查的原因。13项(32%)研究调查了利益相关者对同行审稿人利益冲突的经历,主要使用审稿人、编辑和研究人员的问卷。在期刊、会议和临床指南组织中,有16项(39%)研究估计了同行审稿人利益冲突政策的患病率,从5%到96%不等。最后,6项(15%)研究估计了审稿人利益冲突声明公开的患病率,范围在0%-71%之间。结论:大多数研究主要通过对期刊政策的调查或对研究人员、编辑和同行评议人员的问卷调查来解决期刊手稿同行评议中的利益冲突。同行审稿人的利益冲突对推荐的影响及其普遍程度仍然知之甚少。我们的结果可以指导未来的研究,并用于调整同行审稿人利益冲突的政策和管理。研究注册:开放科学框架(DOI: 10.17605/OSF.IO/9QBMG)。
Peer reviewers' conflicts of interest in biomedical research: scoping review.
Background: Peer review may improve the quality of research manuscripts and aid in editorial decisions, but reviewers can have conflicts of interest that impact on their recommendations.
Objectives: The objective was to systematically map and describe the extent and nature of empirical research on peer reviewers' conflicts of interest in biomedical research.
Design: Scoping review METHODS: In this scoping review, we included studies investigating peer reviewers' conflicts of interest in journal manuscripts, theses and dissertations, conference abstracts, funding applications and clinical guidelines. We searched MEDLINE, Embase, The Cochrane Methodology Register, Google Scholar (up to January 2024) and other sources. Two authors independently included studies and extracted data on key study characteristics and results, and we organised data by study domain (eg, journal manuscripts) and study aims. We included studies directly investigating peer reviewers' conflicts of interest in our primary analysis, and studies investigating other questions (eg, reasons for retraction), but reporting relevant data on peer reviewers' conflicts of interest, were solely included in a supplementary analysis.
Results: After screening 44 353 references, we included 71 studies, of which 41 were included in our primary analysis. The 41 studies were published between 2005 and 2023, and 34 (83%) were journal publications. 30 (73%) studies investigated journal manuscripts, 1 (2%) conference abstracts, 4 (10%) funding applications and 6 (15%) clinical guidelines. No studies investigated theses or dissertations. 37 (90%) studies used quantitative research methods, 2 (5%) qualitative and 2 (5%) mixed methods. 21 (51%) studies investigated both financial and non-financial interests, 6 (15%) solely financial interests, 5 (12%) solely non-financial interests and 9 (22%) did not report the type of interest. We organised included studies based on study aims, with some studies having multiple aims: impact on recommendations (one study), occurrence of peer reviewers' conflicts of interest (11 studies), stakeholders' experiences (13 studies) and policy and management (22 studies). One (2%) study investigated the impact of peer reviewers' personal connections with authors on reviewers' recommendations. Nine (22%) studies estimated prevalences of conflicts of interest among peer reviewers, ranging from 3%-91%. Two (5%) studies both reported that conflicts of interest were a reason for declining to review in 1% of cases. 13 (32%) studies investigated stakeholders' experiences with peer reviewers' conflicts of interest, primarily using questionnaires of reviewers, editors and researchers. 16 (39%) studies estimated prevalences of having conflict of interest policies for peer reviewers, ranging from 5%-96%, among journals, conferences and clinical guideline organisations. Finally, six (15%) studies estimated prevalences of public availabilities of reviewers' conflicts of interest declarations, ranging from 0%-71%.
Conclusions: Most studies addressed conflicts of interest in peer review of journal manuscripts, primarily through surveys of journal policies or questionnaires of researchers, editors and peer reviewers. The impact of peer reviewers' conflicts of interest on recommendations and their prevalence is still poorly understood. Our results can guide future studies and be used to align policies and management of peer reviewers' conflicts of interest.
Study registration: Open Science Framework (DOI: 10.17605/OSF.IO/9QBMG).
期刊介绍:
BMJ Evidence-Based Medicine (BMJ EBM) publishes original evidence-based research, insights and opinions on what matters for health care. We focus on the tools, methods, and concepts that are basic and central to practising evidence-based medicine and deliver relevant, trustworthy and impactful evidence.
BMJ EBM is a Plan S compliant Transformative Journal and adheres to the highest possible industry standards for editorial policies and publication ethics.